Emil Hagström

21.4k total citations · 2 hit papers
119 papers, 4.1k citations indexed

About

Emil Hagström is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Emil Hagström has authored 119 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Cardiology and Cardiovascular Medicine, 35 papers in Surgery and 19 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Emil Hagström's work include Lipoproteins and Cardiovascular Health (30 papers), Acute Myocardial Infarction Research (24 papers) and Cardiac Health and Mental Health (17 papers). Emil Hagström is often cited by papers focused on Lipoproteins and Cardiovascular Health (30 papers), Acute Myocardial Infarction Research (24 papers) and Cardiac Health and Mental Health (17 papers). Emil Hagström collaborates with scholars based in Sweden, United States and New Zealand. Emil Hagström's co-authors include Per Hellman, Claes Held, Lars Lind, Johan Ärnlöv, Johan Sundström, Lars Wallentin, Peter Arner, Håkan Melhus, Karl Michaëlsson and Ralph Stewart and has published in prestigious journals such as The Lancet, JAMA and Nucleic Acids Research.

In The Last Decade

Emil Hagström

107 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data

2021 179 citations Nermin Hadziosmanovic, Johan Sundström et al. profile →
Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry

2025 14 citations Margrét Leósdóttir, Jessica Schubert et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emil Hagström Sweden	37	1.4k	824	745	686	653	119	4.1k
Cassianne Robinson‐Cohen United States	38	666 0.5×	672 0.8×	1.7k 2.3×	881 1.3×	749 1.1×	105	4.3k
Shao‐Yuan Chuang Taiwan	37	2.0k 1.4×	764 0.9×	815 1.1×	365 0.5×	763 1.2×	157	4.8k
Alper Sönmez Türkiye	41	1.2k 0.9×	918 1.1×	1.0k 1.4×	332 0.5×	750 1.1×	169	4.9k
Barış Afşar Türkiye	35	904 0.6×	778 0.9×	1.9k 2.5×	411 0.6×	550 0.8×	218	4.5k
E. B. Pedersen Denmark	36	1.8k 1.3×	617 0.7×	933 1.3×	351 0.5×	670 1.0×	239	5.1k
Rachel H. Mackey United States	37	1.9k 1.3×	987 1.2×	221 0.3×	321 0.5×	720 1.1×	109	4.8k
Κωνσταντίνος Τζιόμαλος Greece	45	1.5k 1.1×	1.7k 2.1×	443 0.6×	503 0.7×	917 1.4×	308	7.7k
Shoaib Afzal Denmark	39	567 0.4×	750 0.9×	187 0.3×	1.1k 1.6×	1.1k 1.7×	168	4.9k
Sophie Liabeuf France	33	559 0.4×	631 0.8×	2.6k 3.5×	404 0.6×	479 0.7×	143	4.6k
Kazuhiko Tsuruya Japan	44	1.1k 0.8×	988 1.2×	3.6k 4.8×	981 1.4×	861 1.3×	399	7.1k

Countries citing papers authored by Emil Hagström

Since Specialization

Citations

This map shows the geographic impact of Emil Hagström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emil Hagström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emil Hagström more than expected).

Fields of papers citing papers by Emil Hagström

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emil Hagström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emil Hagström. The network helps show where Emil Hagström may publish in the future.

Co-authorship network of co-authors of Emil Hagström

This figure shows the co-authorship network connecting the top 25 collaborators of Emil Hagström. A scholar is included among the top collaborators of Emil Hagström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emil Hagström. Emil Hagström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hagström, Emil, et al.. (2025). Utilization and discontinuation of secondary prevention pharmacotherapy after myocardial infarction: a nationwide cohort study. European Heart Journal - Cardiovascular Pharmacotherapy. 12(1). 15–24.

Johansson, Madeleine, Göran Bergström, Tomas Jernberg, et al.. (2025). Severe-extensive coronary atherosclerosis in low-risk individuals and absence of coronary atherosclerosis in high-risk individuals: the SCAPIS extremes project. European Journal of Preventive Cardiology.

Leósdóttir, Margrét, Jessica Schubert, Julia Brandts, et al.. (2025). Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry. Journal of the American College of Cardiology. 85(15). 1550–1564. 14 indexed citations breakdown →

Herráiz-Adillo, Ángel, Viktor H. Ahlqvist, Sara Higueras‐Fresnillo, et al.. (2024). Physical fitness in male adolescents and atherosclerosis in middle age: a population-based cohort study. British Journal of Sports Medicine. 58(8). 411–421. 7 indexed citations

Batra, Gorav, Nermin Hadziosmanovic, Emil Hagström, et al.. (2024). Associations between psychosocial burden and prognostic biomarkers in patients with chronic coronary syndrome: a STABILITY substudy. European Journal of Preventive Cardiology. 32(6). 456–465. 1 indexed citations

Grace, Sherry L., Emil Hagström, Alexander Harrison, et al.. (2024). Cardiac rehabilitation registries around the globe: current status and future needs. European Journal of Preventive Cardiology. 31(16). e117–e121. 2 indexed citations

Schubert, Jessica, et al.. (2023). Association between non–high-density lipoprotein cholesterol change and major adverse outcomes after myocardial infarction. Atherosclerosis. 379. S56–S56. 1 indexed citations

Hagström, Emil, Nermin Hadziosmanovic, Mirjam Ljunggren, et al.. (2023). Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome. International Journal of Cardiology. 394. 131395–131395. 3 indexed citations

Lundman, Pia, Joakim Alfredsson, Emil Hagström, et al.. (2023). Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population. Scientific Reports. 13(1). 12171–12171. 16 indexed citations

10.

Stattin, Eva‐Lena, Emil Hagström, Niklas Dahl, et al.. (2022). Cohort profile: the Swedish study of SUDden cardiac Death in the Young (SUDDY) 2000–2010: a complete nationwide cohort of SCDs. BMJ Open. 12(5). e055557–e055557. 5 indexed citations

11.

Wallentin, Lars, Niclas Eriksson, Tanja B. Grammer, et al.. (2021). Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study. PLoS Medicine. 18(1). e1003513–e1003513. 86 indexed citations

12.

Bäck, Maria, Margrét Leósdóttir, Emil Hagström, et al.. (2021). The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry). European Heart Journal - Quality of Care and Clinical Outcomes. 7(5). 431–437. 36 indexed citations

13.

Venetsanos, Dimitrios, David Erlinge, Emil Hagström, et al.. (2021). Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention. Heart. 107(14). 1145–1151. 18 indexed citations

14.

Schubert, Jessica, Bertil Lindahl, Håkan Melhus, et al.. (2020). Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study. European Heart Journal. 42(3). 243–252. 109 indexed citations

15.

Jernberg, Tomas, et al.. (2020). Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study. European Heart Journal. 41(40). 3900–3909. 72 indexed citations

16.

Ridefelt, Peter, Emil Hagström, Maria Svensson, Torbjörn Åkerfeldt, & Anders Larsson. (2019). Age- and sex-specific reference values for non-HDL cholesterol and remnant cholesterol derived from the Nordic Reference Interval Project (NORIP). Scandinavian Journal of Clinical and Laboratory Investigation. 79(1-2). 39–42. 11 indexed citations

17.

Hagström, Emil, Daniel Wojdyla, Megan L. Neely, et al.. (2015). Management and clinical consequences of major bleeding in high-risk patients following an acute coronary syndrome. Is aspirin the problem? : Insights from the APPRAISE-2 trial. European Heart Journal. 36. 861–862. 3 indexed citations

18.

Hagström, Emil, Niclas Eriksson, Åsa Johansson, et al.. (2013). Are There Any Causal Relations Between Growth Differentiation Factor 15 and Outcomes in Patients With Acute Coronary Syndrome? : - A Report From the Plato Gwas Study. Circulation. 128(22). 2 indexed citations

19.

Hagström, Emil, Erik Ingelsson, Johan Sundström, et al.. (2010). Plasma Parathyroid Hormone and Risk of Congestive Heart Failure in the Community. European Journal of Heart Failure. 12(11). 1186–1192. 87 indexed citations

20.

Hagström, Emil, Ewa Lundgren, Hans Lithell, et al.. (2001). Normalised dyslipidemia after parathyroidectomy in mild primary hyperparathyroidism. A population-based case-control study over five years.. Clinical Endocrinology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact